Untuk Rekan yang sudah tahu mengenai bahayanya PPA (Phenyl Propanol Amine) yang 
bisa menyebabkan penyakit stroke bilamana dipakai terus menerus, mungkin sudah 
faham, bahwa banyak sekali produk obat flu yang sudah mengganti komposisinya 
dari PPA (Phenyl Propanol Amine) menjadi PseudoEphedrine, seperti misalnya 
produk Inza yang sudah tidak menggunakan PPA. dengan komposisi baru yang lebih 
aman.......yaitu Pseudoephedrine.
   
  Hal tersebut terpaksa dilakukan meskipun PseudoEphedrine harganya lebih 
mahal... tetapi PPA sudah dilarang bahkan oleh FDA (Food and Drug 
Administration) di Amerika, yang mencantumkan bahayanya PPA, seperti terlihat 
pada website berikut:
   
  http://www.fda.gov/bbs/topics/ANSWERS/ANS01051.html
   
  Tetapi Produk Sanaflu masih menggunakan PPA yang berbahaya, selain itu juga 
sebetulnya produk ini tidak manjur..... untuk Flu, karena umumnya obat Flu 
mengandung 3 komponen:
  1. Anti nyeri/ Anti Panas.................biasanya Paracetamol....
  2. Dekongestan.......obat kuno pakai PPA, sedangkan obat yang lebih aman 
pakai Pseudoephedrine.
  3. Anti allergi...................umumnya CTM atau diphenhydramine. memang 
mengakibatkan kantuk.
   
  Sedangkan Sanaflu agar murah hanya memakai 2 komponen ke-1 dan ke-2. dan 
untuk komponen 2 masih memakai obat kuno PPA yang berbahaya.
  Seharusnya obat ini harganya MURAH sekali.....karena menghemat dengan hanya 
terdiri atas 2 jenis obat. dan menggunakan bahan yang KUNO dan BERBAHAYA dan 
PELIT bahan.........
   
  dan bila digunakan terus, bisa menyebabkan penyakit STROKE dan JANTUNG !!!!
   
  Terlampir di bawah ini adalah peringatan dari FDA mengenai bahayanya PPA yang 
terkandung juga di Sanaflu...
   
  Jadi...sekali lagi...jangan terpancing oleh hebatnya Iklan TV atau iklan 
Radio atau Iklan majalah dan koran..... memang cukup aneh bahwa justru obat 
yang berbahaya bisa beriklan dengan gencar dengan hanya sedikit mencantumkan 
resiko dan bahayanya........
   
    
---------------------------------
  

T00-58                                                  Print Media:  
301-827-6242  November 6, 2000                                                 
Consumer Inquiries:888-INFO-FDA  
  
---------------------------------
    FDA ISSUES PUBLIC HEALTH WARNING ON PHENYLPROPANOLAMINE   FDA, today, is 
taking steps to remove phenylpropanolamine from all drug products and has 
requested that all drug companies discontinue marketing products containing 
phenylpropanolamine.
  FDA today issued a public health advisory concerning the risk of hemorrhagic 
stroke, or bleeding into the brain, associated with phenylpropanolamine 
hydrochloride.     Phenylpropanolamine is an ingredient used in many 
over-the-counter (OTC) and prescription cough and cold medications as a 
decongestant and in OTC weight loss products. 
  Adverse events reported with these products led to concerns that this 
ingredient might increase the risk of hemorrhagic strokes. Manufacturers of 
products containing phenylpropanolamine worked with FDA to plan a research 
program to clarify whether any increase in risk exists.
  Scientists at Yale University School of Medicine conducted the study in which 
the researchers found an association between phenylpropanolamine use and stroke 
in women. The increased risk of hemorrhagic stroke was detected among women 
using the drug for weight control, and for nasal decongestion, in the 3 days 
after starting use of the medication. Men may also be at risk.
  The Nonprescription Drugs Advisory Committee met on October 19 to discuss 
safety issues related to phenylpropanolamine use. The committee reviewed Yale’s 
Hemorrhagic Stroke Project results and concluded that phenylpropanolamine 
cannot be considered to be safe for continued use. 
  
  FDA believes that although the risk of hemorrhagic stroke is very low, even 
with phenylpropanolamine use, the conditions for which these products are used 
do not appear to warrant an increased risk of this serious event from using 
this drug. We advise consumers to discuss alternative over-the-counter and 
prescription products with their health care providers or pharmacists.
  Information about the history of phenylpropanolamine, the Public Health 
Advisory, and the stroke study results can be found on the FDA website 
at:www.fda.gov/cder/drug/infopage/ppa/default.htm.
  
---------------------------------
    FDA News Page   |   FDA Home Page
    Office of Public Affairs
Web page created by jch 2000-NOV-06. 




                        
---------------------------------
 Yahoo! Mail - Helps protect you from nasty viruses.

[Non-text portions of this message have been removed]



Subscribe: [EMAIL PROTECTED]
Unsubscribe: [EMAIL PROTECTED]

Info Belanja si Kecil: [EMAIL PROTECTED]
 
Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/Ayahbunda-Online/

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 


Kirim email ke